Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis

Guang Peng1, Dan A Dixon, Stephanie J Muga

  • 1Department of Pathology and Microbiology, School of Medicine, The University of South Carolina, and South Carolina Cancer Center, Columbia, South Carolina 29203, USA.

Insights

Green tea

Area of Science:

  • Oncology
  • Molecular Biology
  • Nutritional Science

Background:

  • Green tea consumption is linked to anti-cancer effects, particularly in colon cancer.
  • Cyclooxygenase-2 (COX-2) overexpression is implicated in colon cancer development.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) show chemopreventive potential by inhibiting COX-2.

Purpose of the Study:

  • To investigate if green tea's anti-cancer properties involve the modulation of COX-2 expression.
  • To determine the specific mechanisms by which green tea polyphenols affect COX-2 in colon cancer cells.

Main Methods:

  • Human colorectal cancer cell lines (HT-29 and HCA-7) were treated with (-)-epigallocatechin-3-gallate (EGCG).
  • Analysis of COX-2 mRNA and protein levels, signaling pathways (ERK1/2, Akt), and NF-kappaB activation.
  • Investigation of COX-2 promoter activity and mRNA decay via the 3'UTR.

Main Results:

  • EGCG significantly inhibited both COX-2 mRNA and protein overexpression in colon cancer cells.
  • EGCG downregulated the ERK1/2 and Akt signaling pathways.
  • EGCG reduced COX-2 promoter activity by inhibiting NF-kappaB activation and promoted mRNA decay.

Conclusions:

  • Inhibition of COX-2 is a key mechanism underlying green tea's anti-proliferative effects in colon cancer.
  • Dietary factors like green tea polyphenols play a significant role as anti-cancer agents.
  • EGCG's multifaceted action on COX-2 regulation highlights its therapeutic potential.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...